Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Bipolar Disorder: HELP
Osama A. Abulseoud
Based on 7 articles published since 2010
(Why 7 articles?)
||||
Expertise Level
The expertise of Osama A. Abulseoud ranks in the
  • Top 4.4%
  • ... of 40,616 published authors worldwide on Bipolar Disorder
  • ... from 2010 through 2020
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Aliases Abulseoud, O   ·   Abulseoud, O A   ·   Abulseoud, Osama A   ·   Abulseoud, Osama
Work Locations
Details
Most likely:    National Institutes of Health      
2020
  • Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, USA. · University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital Psychiatry Department, Bursa, Turkey. · Bakirkoy Research & Training Hospital for Psychiatry, Neurology, Neurosurgery and Psychiatry Department, İstanbul, Turkey. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Pubmed 32053271
2018
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Psychiatry, University of Texas Health Science Center at Houston and McGovern Medical School, Houston, TX, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, United States. Electronic address: · Pubmed 29309958
2017
  • Department of Psychiatry and Psychology; Mayo Clinic, Rochester, Minnesota, United States of America. · Chemistry and Drug Metabolism, IRP, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America. · University of Belgrade, Faculty of Physical Chemistry, Studentski trg 12-16, Belgrade, Serbia. · University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Department of Catalysis and Chemical Engineering, Njegoševa 12, Belgrade, Serbia. · Karolinska Institute, Department of Clinical Neuroscience, Center for Molecular Medicine CMM L8:01, Stockholm, Sweden. · Pubmed 28542167
Probable:    Mayo Clinic Rochester      
2018
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Psychiatry, University of Texas Health Science Center at Houston and McGovern Medical School, Houston, TX, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, United States. Electronic address: · Pubmed 29309958
2017
  • Department of Psychiatry and Psychology; Mayo Clinic, Rochester, Minnesota, United States of America. · Chemistry and Drug Metabolism, IRP, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America. · University of Belgrade, Faculty of Physical Chemistry, Studentski trg 12-16, Belgrade, Serbia. · University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Department of Catalysis and Chemical Engineering, Njegoševa 12, Belgrade, Serbia. · Karolinska Institute, Department of Clinical Neuroscience, Center for Molecular Medicine CMM L8:01, Stockholm, Sweden. · Pubmed 28542167
2015
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · 1] Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA [2] Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · Pubmed 25803497
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Department of Radiology, Psychiatry, and Biomedical Engineering, Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. · Department of Radiology, Mayo Clinic, Rochester, MN, USA. · University of Louisville School of Medicine, Louisville, KY, USA. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · Pubmed 25495884
Possible:    UCLA   Contact    
2010
  • Department of Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. · Pubmed 20515320
  • VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6968, USA. · Pubmed 20712756
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Osama A. Abulseoud in 2010-2020 about Bipolar Disorder:

  • Sex difference in the progression of manic symptoms during acute hospitalization: A prospective pilot study. 2020
  • No differences in manic-like behaviors between voluntary ethanol and water drinking in Lateral Hypothalamic Kindled (LHK) alcohol preferring rats. 2018
  • Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat-Experimental observations and mathematical modeling. 2017
  • Sex differences in mania phenotype and ethanol consumption in the lateral hypothalamic kindled rat model. 2015
  • N-acetylaspartate normalization in bipolar depression after lamotrigine treatment. 2015
  • Improving the design of maintenance studies for bipolar disorder. 2010
  • Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. 2010
Show List of Full Article Records
Google Searches

Learn more about Osama A. Abulseoud using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
Mayo Clinic Rochester
UCLA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2020
  • Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, USA. · University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital Psychiatry Department, Bursa, Turkey. · Bakirkoy Research & Training Hospital for Psychiatry, Neurology, Neurosurgery and Psychiatry Department, İstanbul, Turkey. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Pubmed 32053271
2018
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Psychiatry, University of Texas Health Science Center at Houston and McGovern Medical School, Houston, TX, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, United States. Electronic address: · Pubmed 29309958
2017
  • Department of Psychiatry and Psychology; Mayo Clinic, Rochester, Minnesota, United States of America. · Chemistry and Drug Metabolism, IRP, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America. · University of Belgrade, Faculty of Physical Chemistry, Studentski trg 12-16, Belgrade, Serbia. · University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Department of Catalysis and Chemical Engineering, Njegoševa 12, Belgrade, Serbia. · Karolinska Institute, Department of Clinical Neuroscience, Center for Molecular Medicine CMM L8:01, Stockholm, Sweden. · Pubmed 28542167
Mayo Clinic Rochester
2018
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Psychiatry, University of Texas Health Science Center at Houston and McGovern Medical School, Houston, TX, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States. · Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Neuroimaging Research Branch, IRP, National Institute on Drug Abuse, Baltimore, MD, United States. Electronic address: · Pubmed 29309958
2017
  • Department of Psychiatry and Psychology; Mayo Clinic, Rochester, Minnesota, United States of America. · Chemistry and Drug Metabolism, IRP, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America. · University of Belgrade, Faculty of Physical Chemistry, Studentski trg 12-16, Belgrade, Serbia. · University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Department of Catalysis and Chemical Engineering, Njegoševa 12, Belgrade, Serbia. · Karolinska Institute, Department of Clinical Neuroscience, Center for Molecular Medicine CMM L8:01, Stockholm, Sweden. · Pubmed 28542167
2015
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · 1] Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA [2] Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · Pubmed 25803497
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. · Department of Radiology, Psychiatry, and Biomedical Engineering, Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. · Department of Radiology, Mayo Clinic, Rochester, MN, USA. · University of Louisville School of Medicine, Louisville, KY, USA. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. · Pubmed 25495884
UCLA
2010
  • Department of Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. · Pubmed 20515320
  • VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6968, USA. · Pubmed 20712756
Veterans Health System
2010
  • VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6968, USA. · Pubmed 20712756
Yearly article counts 10110200002
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.